Pharmaceutical

LSPedia and Pharma Logistics Announce Strategic Partnership to Revolutionize Pharmaceutical Reverse Logistics and Supply Chain Visibility

FARMINGTON HILLS, Mich., Aug. 13, 2024 /PRNewswire/ -- LSPedia, a SaaS solution leader in global product traceability, proudly announces a…

1 year ago

Authenticx Announces AI Solution Revolutionizing Adverse Event Reporting

Latest product for detecting healthcare-specific compliance events and streamlining reporting INDIANAPOLIS, Aug. 13, 2024 /PRNewswire/ -- Authenticx, the new standard in…

1 year ago

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Up to $16 Million Senior Secured Debt Financing from Anson Funds

This financing is expected to support 2024 filing of New Drug Applications forNRX-100 (ketamine) and NRX-101 and to support launch…

1 year ago

Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit

AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development PLEASANTON, Calif., Aug. 13, 2024…

1 year ago

Acclinate Ranks No. 539 on the 2024 Inc. 5000 List

NEW YORK, Aug. 13, 2024 /PRNewswire/ -- Inc. magazine revealed today that Acclinate has ranked No. 539 on its 2024…

1 year ago

Leapcure Acquires Honeybee Trials: Expanding Patient Engagement and Research Site Solutions for Clinical Trials

Leapcure enhances clinical trials and affordable patient recruitment with strategic acquisition of Honeybee Trials.REDWOOD CITY, CA / ACCESSWIRE / August…

1 year ago

Affordable Prescription Solutions by CostPill

0% Markup on Generics, Best Prices for Brand and OTC MedicationsNEWARK, CA / ACCESSWIRE / August 13, 2024 / CostPill,…

1 year ago

Gilead and the Elton John AIDS Foundation Announce Additional Five Years of RADIAN Partnership To Help Address the Growing HIV Crisis in Eastern Europe and Central Asia

RADIAN's Five-Year, $25 Million Extension Will Increase Support for Local Organizations and Drive Progress to Help Turn the Tide on…

1 year ago

Jaguar Health Reports Second Quarter 2024 Financial Results

The combined net Q2 2024 revenue of approximately $2.72 million for prescription and non-prescription products increased approximately 16% versus net…

1 year ago